Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-06

Clinical Trial Update: Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing nevirapine drug levels in HIV-positive patients concurrently treated with rifampicin for tuberculosis; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)
  • Rifampicin

Snippet

Sponsor: Makerere University | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: COMPLETED